|
NFS1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.287640E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.297800E-02 |
| Normal-vs-Stage2 |
1.901580E-01 |
| Normal-vs-Stage3 |
4.582300E-02 |
| Normal-vs-Stage4 |
3.059800E-01 |
| Stage1-vs-Stage2 |
7.669000E-01 |
| Stage1-vs-Stage3 |
3.048600E-01 |
| Stage1-vs-Stage4 |
7.542000E-01 |
| Stage2-vs-Stage3 |
6.398200E-01 |
| Stage2-vs-Stage4 |
9.401400E-01 |
| Stage3-vs-Stage4 |
7.670800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.970100E-02 |
| Normal-vs-AfricanAmerican |
1.779710E-03 |
| Normal-vs-Asian |
2.114200E-01 |
| Caucasian-vs-AfricanAmerican |
5.972000E-02 |
| Caucasian-vs-Asian |
8.168800E-01 |
| AfricanAmerican-vs-Asian |
6.974800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.259500E-02 |
| Normal-vs-Female |
3.079600E-02 |
| Male-vs-Female |
5.628800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.284200E-03 |
| Normal-vs-Extreme_Weight |
9.996200E-03 |
| Normal-vs-Obese |
9.458000E-02 |
| Normal-vs-Extreme_Obese |
2.754200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.387000E-01 |
| Normal_Weight-vs-Obese |
1.364810E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.511400E-01 |
| Extreme_Weight-vs-Obese |
4.797800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.733400E-01 |
| Obese-vs-Extreme_Obese |
9.605200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.879600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.961600E-02 |
| Normal-vs-Age(61-80Yrs) |
1.430040E-02 |
| Normal-vs-Age(81-100Yrs) |
2.516600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.359400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.210400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.786990E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.776200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.367800E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.007800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.155370E-01 |
| Normal-VS-Type2 PRCC |
5.642600E-03 |
| Normal-VS-KIRP CIMP |
3.376300E-03 |
| Normal-VS-Unclassified PRCC |
8.086600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.397700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.111050E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.060800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.424200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.108240E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.778500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.780400E-02 |
| Normal-vs-N1 |
4.999700E-03 |
| Normal-vs-N2 |
4.935900E-03 |
| N0-vs-N1 |
3.833000E-01 |
| N0-vs-N2 |
3.252000E-01 |
| N1-vs-N2 |
4.821000E-01 |
|
|
